This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Misstatement In Operative Report Not A Crime, Doctors' Group Tells Court

TUCSON, Ariz., Jan. 15, 2013 /PRNewswire-USNewswire/ -- In a motion for leave to file an amicus brief, the Association of American Physicians and Surgeons tells the Court that the criminalization of language used in medical reports will have a profoundly chilling effect on the practice of medicine.

In November, 2012, John Natale, M.D., of Chicago, a cardiothoracic and vascular surgeon, went to federal prison on charges related to difficult, life-saving operations on several patients performed nearly 10 years ago. The patients survived and did well despite an expected mortality of 90 percent.

Natale was accused of Medicare fraud because of billing under an AMA procedure (CPT) code allegedly representing a more complex operation than the one he did. He was acquitted by the jury on all counts related to fraud.

He was, however, convicted on two counts of making "false statements," and Judge Rebecca Pallmeyer decided a prison sentence was needed to send a message to all physicians about the importance of accurate reporting for the financial stability of the Medicare program.

Natale routinely worked from 5:30 a.m. until late at night, and habitually was behind in dictating his operative reports. He incorrectly stated that he had used a bifurcation or Y-graft in repairing an abdominal aortic aneurysm, instead of the straight tube graft actually used. This made no difference in the billing, and there was no evidence that Natale "knowingly" and "willfully" made a false statement in order to violate the law.

The government refused consent for AAPS to file the brief; hence the need for a motion to the Court to accept it.

AAPS argues that the trial court erred in expanding the statute far beyond its legitimate scope, sweeping in misstatements "lacking materiality, lacking fraud, and lacking any proof of willfulness." In other words, there was no proof of a mens rea, or criminal intent.

"False statements can be found in any voluminous body of work, but that does not make them federal crimes."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs